5-HT(6) receptor and cognition
Palabras clave : 
5-HT6 receptors
Alzheimer's disease
Fecha incorporación: 
2011
Editorial : 
Elsevier
ISSN: 
1471-4973
Cita: 
Codony X, Vela JM, Ramirez MJ. 5-HT(6) receptor and cognition. Curr Opin Pharmacol 2011 Feb;11(1):94-100.
Resumen
Since its discovery in 1993 and subsequent development of selective antagonists, a growing number of studies support the use of serotonin 5-HT(6) receptor antagonism as a promising mechanism for treating cognitive dysfunction. Lately, several studies with structurally different compounds have shown that not only antagonists, but also 5-HT(6) receptor agonists improve learning and memory in animal models. There is even an antagonist, SB-742457, that has completed phase II trials for the treatment of Alzheimer's disease. In addition to describe preclinical and clinical evidence of the effect of 5-HT(6) receptor compounds on cognition, this article will also focus on the purported biochemical and neurochemical mechanisms of action by which 5-HT(6) receptor compounds could influence cognition in health and disease.

Ficheros en este registro:
Fichero: 
5-HT6 and cognition-4.pdf
Descripción: 
Tamaño: 
163,09 kB
Formato: 
Adobe PDF


Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.